Novel antitussive strategies

Drug Discovery Today

Volumn 18, Issue 7-8, 2013, Pages 380-388

  Morjaria, Jaymin B ^a   Dickinson, Rebecca S ^a   Morice, Alyn H ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTITUSSIVE AGENT; AZITHROMYCIN; BACLOFEN; CAPSAZEPINE; CODEINE; DEXTROMETHORPHAN; ERYTHROMYCIN; GABAPENTIN; LESOGABERAN; MORPHINE; N (4 TERTIARYBUTYLPHENYL) 4 (3 CHLOROPYRIDIN 2 YL)TETRAHYDROPYRASINE 1(2H) CABOX AMIDE; OPIATE; PREGABALIN; SODIUM CHANNEL; THEOBROMINE; UNCLASSIFIED DRUG;

COUGHING; HUMAN; NONHUMAN; REVIEW;

ANIMALS; ANTITUSSIVE AGENTS; COUGH; HUMANS;

EID: 84875703957     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.11.004     Document Type: Review

References (93)

1. H. Britt General Practice Activity in Australia 2001-2 2002 Australian Institute of Health and Welfare
2. D.C. Morrell Symptom interpretation in general practice J. R. Coll. Gen. Pract. 22 1972 297 309
3. M.R. Pratter An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines Chest 129 Suppl. 1 2006 S222 S231
4. R.S. Irwin Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines Chest 129 Suppl. 1 2006 S1 S23
5. A.H. Morice The diagnosis and management of chronic cough Eur. Respir. J. 24 2004 481 492 (Pubitemid 39232274)
6. K.M. Sundar Chronic cough and obstructive sleep apnea in a community-based pulmonary practice Cough 6 2010 2
7. S.S. Birring Idiopathic chronic cough and organ-specific autoimmune diseases: a case-control study Respir. Med. 98 2004 242 246 (Pubitemid 38262658)
8. S.S. Birring Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough Eur. Respir. J. 23 2004 199 201 (Pubitemid 38195502)
9. A. Fahim Glomus vagale presenting as chronic cough Eur. Respir. J. 35 2010 446 447
10. A.H. Morice The cough hypersensitivity syndrome: a novel paradigm for understanding cough Lung 188 Suppl. 1 2010 S87 S90
11. K.F. Chung Chronic 'cough hypersensitivity syndrome': a more precise label for chronic cough Pulm. Pharmacol. Ther. 24 2011 267 271
12. B. Nilius Transient receptor potential cation channels in disease Physiol. Rev. 87 2007 165 217 (Pubitemid 46207713)
13. D.A. Groneberg Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough Am. J. Respir. Crit. Care Med. 170 2004 1276 1280 (Pubitemid 39657190)
14. M.A. Birrell TRPA1 agonists evoke coughing in guinea pig and human volunteers Am. J. Respir. Crit. Care Med. 180 2009 1042 1047
15. N. Patterson Nonacid reflux episodes reaching the pharynx are important factors associated with cough J. Clin. Gastroenterol. 43 2009 414 419
16. A.H. Morice Cough hypersensitivity syndrome: a distinct clinical entity Lung 189 2011 73 79
17. A.H. Morice Opiate therapy in chronic cough Am. J. Respir. Crit. Care Med. 175 2007 312 315
18. T.B. Vree Codeine analgesia is due to codeine-6-glucuronide, not morphine Int. J. Clin. Pract. 54 2000 395 398 (Pubitemid 30604052)
19. P.W. Davenport The effect of codeine on the urge-to-cough response to inhaled capsaicin Pulm. Pharmacol. Ther. 20 2007 338 346 (Pubitemid 46518195)
20. R. Eccles Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection J. Clin. Pharm. Ther. 17 1992 175 180
21. J. Smith Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease J. Allergy Clin. Immunol. 117 2006 831 835
22. T.J. Grattan The effect of inhaled and oral dextromethorphan on citric acid induced cough in man Br. J. Clin. Pharmacol. 39 1995 261 263
23. J. Delgado, and W. Remers Wilson and Gisvold's Textbook of Organic and Medicinal Pharmaceutical Chemistry 1998 Raven Publishers
24. R. Netzer Dextromethorphan blocks N-methyl-d-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons Eur. J. Pharmacol. 238 1993 209 216 (Pubitemid 23214433)
25. Y.C. Chou Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan Brain Res. 821 1999 516 519
26. S.D. Glick Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats Eur. J. Pharmacol. 422 2001 87 90 (Pubitemid 32595579)
27. P. Meoni An autoradiographic study of dextromethorphan high-affinity binding sites in rat brain: sodium-dependency and colocalization with paroxetine Br. J. Pharmacol. 120 1997 1255 1262 (Pubitemid 27149675)
28. D.A. Capon The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans Clin. Pharmacol. Ther. 60 1996 295 307 (Pubitemid 26354450)
29. J. Ramsay Assessment of antitussive efficacy of dextromethorphan in smoking related cough: objective vs. subjective measures Br. J. Clin. Pharmacol. 65 2008 737 741 (Pubitemid 351535094)
30. L. Pavesi Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis Chest 120 2001 1121 1128 (Pubitemid 32960081)
31. A. Woodcock The efficacy of a NOP1 agonist (SCH486757) in subacute cough Lung 188 Suppl. 1 2010 S47 S52
32. M.R. Amin, and J.A. Koufman Vagal neuropathy after upper respiratory infection: a viral etiology? Am. J. Otolaryngol. 22 2001 251 256 (Pubitemid 32718039)
33. N.M. Ryan Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial Lancet 380 2012 1583 1589
34. B. Lee, and P. Woo Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment Ann. Otol. Rhinol. Laryngol. 114 2005 253 257 (Pubitemid 40529978)
35. S.L. Halum A new treatment option for laryngeal sensory neuropathy Laryngoscope 119 2009 1844 1847
36. S.M. Greene, and C.B. Simpson Evidence for sensory neuropathy and pharmacologic management Otolaryngol. Clin. North Am. 43 2010 67 72
37. P.V. Dicpinigaitis Inhibition of capsaicin-induced cough by the gamma-aminobutyric acid agonist baclofen J. Clin. Pharmacol. 38 1998 364 367 (Pubitemid 28194177)
38. P.V. Dicpinigaitis, and K. Rauf Treatment of chronic, refractory cough with baclofen Respiration 65 1998 86 88 (Pubitemid 28076131)
39. A. Jeyakumar Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy Laryngoscope 116 2006 2108 2112 (Pubitemid 44912302)
40. R.W. Bastian Sensory neuropathic cough: a common and treatable cause of chronic cough Otolaryngol. Head Neck Surg. 135 2006 17 21 (Pubitemid 43946545)
41. J. Xu Calcium transient evoked by nicotine in isolated rat vagal pulmonary sensory neurons Am. J. Physiol. Lung Cell. Mol. Physiol. 292 2007 L54 L61
42. P.W. Davenport The urge-to-cough and cough motor response modulation by the central effects of nicotine Pulm. Pharmacol. Ther. 22 2009 82 89
43. L.Y. Lee Nicotine is responsible for airway irritation evoked by cigarette smoke inhalation in men J. Appl. Physiol. 75 1993 1955 1961
44. Y. Muroi, and B.J. Undem Targeting peripheral afferent nerve terminals for cough and dyspnea Curr. Opin. Pharmacol. 11 2011 254 264
45. A. Lehmann Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation Br. J. Pharmacol. 165 2012 1757 1772
46. L. Branden The novel, peripherally restricted GABAB receptor agonist lesogaberan (AZD3355) inhibits acid reflux and reduces esophageal acid exposure as measured with 24-h pHmetry in dogs Eur. J. Pharmacol. 634 2010 138 141
47. M. Niazi Evaluation of the pharmacokinetic interaction between lesogaberan (AZD3355) and esomeprazole in healthy subjects Drugs R. D. 10 2010 243 251
48. M. Niazi Pharmacokinetic profile of lesogaberan (AZD3355) in healthy subjects: a novel GABA(B)-receptor agonist reflux inhibitor Drugs R. D. 11 2011 77 83
49. G.E. Boeckxstaens Effect of lesogaberan, a novel GABA(B)-receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects Aliment. Pharmacol. Ther. 31 2010 1208 1217
50. G.E. Boeckxstaens Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease Gastroenterology 139 2010 409 417
51. G.E. Boeckxstaens A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial Gut 60 2011 1182 1188
52. M. Trevisani Antitussive activity of iodo-resiniferatoxin in guinea pigs Thorax 59 2004 769 772 (Pubitemid 39215373)
53. M. Rigoni Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin Br. J. Pharmacol. 138 2003 977 985 (Pubitemid 36390655)
54. K.J. Valenzano N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl) tetrahydropyrazine-1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. In vitro characterization and pharmacokinetic properties J. Pharmacol. Exp. Ther. 306 2003 377 386 (Pubitemid 36734395)
55. R.L. McLeod TRPV1 antagonists attenuate antigen-provoked cough in ovalbumin sensitized guinea pigs Cough 2 2006 10
56. A. Bhattacharya Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs J. Pharmacol. Exp. Ther. 323 2007 665 674 (Pubitemid 350005126)
57. S.Y. Leung Inhibition of citric acid- and capsaicin-induced cough by novel TRPV-1 antagonist, V112220, in guinea-pig Cough 3 2007 10
58. A.L. Krarup Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain Aliment. Pharmacol. Ther. 33 2011 1113 1122
59. N.R. Gavva Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans Pain 136 2008 202 210
60. S.G. Lehto Antihyperalgesic effects of (R, E)-N-(2-hydroxy-2,3-dihydro- 1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluorom ethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats J. Pharmacol. Exp. Ther. 326 2008 218 229 (Pubitemid 351872146)
61. E. Andre Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents J. Clin. Invest. 118 2008 2574 2582 (Pubitemid 351949784)
62. M. Petrus A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition Mol. Pain 3 2007 40
63. S.R. Eid HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity Mol Pain 4 2008 48
64. A.I. Caceres A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma Proc. Natl. Acad. Sci. U. S. A. 106 2009 9099 9104
65. E. Andre Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents Br. J. Pharmacol. 158 2009 1621 1628
66. B. Hille Potassium channels and chloride channels B.D. Hiile, Ion Channels of Excitable Membranes 2001 Sinauer Associates 134 167
67. C.D. Sarantopoulos Opposing effects of spinal nerve ligation on calcium-activated potassium currents in axotomized and adjacent mammalian primary afferent neurons Brain Res. 1132 2007 84 99 (Pubitemid 46099005)
68. T. Kawano ATP-sensitive potassium currents in rat primary afferent neurons: biophysical, pharmacological properties, and alterations by painful nerve injury Neuroscience 162 2009 431 443
69. M. Sutovska The role of potassium ion channels in cough and other reflexes of the airways J. Physiol. Pharmacol. 58 Suppl. 5; Pt 2 2007 673 683 (Pubitemid 351346717)
70. A.J. Fox Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig J. Clin. Invest. 99 1997 513 519 (Pubitemid 27414810)
71. K. Morita, and J. Kamei Involvement of ATP-sensitive K(+) channels in the anti-tussive effect of moguisteine Eur. J. Pharmacol. 395 2000 161 164 (Pubitemid 30224821)
72. C.K. Raymond Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia J. Biol. Chem. 279 2004 46234 46241 (Pubitemid 39491618)
73. M.F. Jarvis A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat Proc. Natl. Acad. Sci. U. S. A. 104 2007 8520 8525 (Pubitemid 47175520)
74. Y. Muroi Selective silencing of Na(V)1.7 decreases excitability and conduction in vagal sensory neurons J. Physiol. 589 2011 5663 5676
75. T. Weiser, and N. Wilson Inhibition of tetrodotoxin (TTX)-resistant and TTX-sensitive neuronal Na(+) channels by the secretolytic ambroxol Mol. Pharmacol. 62 2002 433 438 (Pubitemid 36329359)
76. J. Kamei Possible involvement of tetrodotoxin-resistant sodium channels in cough reflex Eur. J. Pharmacol. 652 2011 117 120
77. S.B. Mazzone, and A.E. McGovern Immunohistochemical characterization of nodose cough receptor neurons projecting to the trachea of guinea pigs Cough 4 2008 9
78. - channels regulate citric acid cough in guinea pigs J. Appl. Physiol. 101 2006 635 643 (Pubitemid 44162375)
79. B.K. Rubin, and M.O. Henke Immunomodulatory activity and effectiveness of macrolides in chronic airway disease Chest 125 Suppl. 2 2004 70S 78S (Pubitemid 38200963)
80. N. Yousaf Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial Thorax 65 2010 1107 1110
81. V. Mertens Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients Dig. Dis. Sci. 54 2009 972 979
82. V. Mertens Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin Am. J. Transplant. 11 2011 329 335
83. R.K. Albert Azithromycin for prevention of exacerbations of COPD N. Engl. J. Med. 365 2011 689 698
84. B. Moshiree Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis Dig. Dis. Sci. 55 2010 675 683
85. M.G. Crooks Azithromycin for prevention of exacerbations of COPD N. Engl. J. Med 365 2011 2234 2235 author reply 2236
86. J.A. Beavo Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms Physiol. Rev. 75 1995 725 748
87. A.T. Bender, and J.A. Beavo Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use Pharmacol. Rev. 58 2006 488 520 (Pubitemid 44394910)
88. S.B. Karish, and J.M. Gagnon The potential role of roflumilast: the new phosphodiesterase-4 inhibitor Ann. Pharmacother. 40 2006 1096 1104 (Pubitemid 43886967)
89. E.G. Mikus Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4- oxadiazol-3-yl)methyl], 2nd communication: investigations on theophylline-like activities Arzneimittelforschung 47 1997 1358 1363 (Pubitemid 28015502)
90. O.S. Usmani Theobromine inhibits sensory nerve activation and cough FASEB J. 19 2005 231 233 (Pubitemid 40189265)
91. J. Mokry, and G. Nosalova The influence of the PDE inhibitors on cough reflex in guinea pigs Bratisl. Lek. Listy 112 2011 131 135
92. J. Mokry Influence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity J. Physiol. Pharmacol. 59 Suppl. 6 2008 473 482
93. M. Fujimura, and Q. Liu Selective inhibitors for phosphodiesterase 3 and 4 in antigen-induced increase of cough reflex sensitivity in guinea pigs Pulm. Pharmacol. Ther. 20 2007 543 548 (Pubitemid 47077645)